P47870 (GBRB2_HUMAN) Homo sapiens (Human)
Gamma-aminobutyric acid receptor subunit beta-2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
19 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Complex of GABA-A synaptic receptor with autoimmune antibody Fab175 |
Heteromer P14867; P18507; | 100 | 3×NAG; 2×NAG; 1×NAG; 2×ABU; 2×NAG; 1×MAN; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 6×PTY; 1×Q3G; 1×A8W; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus DMCM |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 3×R63; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×V8D; | |||
| Complex of GABA-A synaptic receptor with autoimmune antibody Fab115 |
Heteromer P14867; P18507; | 100 | 4×NAG; 2×NAG; 1×NAG; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×Y4B; 2×ABU; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus Zolpidem |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 3×R5R; 2×ABU; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone s… |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×ZWY; 6×PTY; 1×Q3G; 1×POV; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×PFL; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×RI5; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam |
Heteromer P14867; P18507; | 100 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 4×DZP; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide |
Heteromer P14867; P18507; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×J94; 1×MAN; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA |
Heteromer P14867; P18507; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital |
Heteromer P14867; P18507; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 2×UQA; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil |
Heteromer P14867; P18507; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 1×FYP; | |||
| Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P18507; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 12×Y01; 1×FYP; | |||
| Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P18507; | 100 | 2×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 12×Y01; 1×FYP; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus PPTQ |
Heteromer P14867; P18507; | 100 | 3×NAG; 3×NAG; 1×NAG; 2×ABU; 2×A1ADN; 5×PTY; 1×POV; 2×Q3G; | |||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus methaqualone |
Heteromer P14867; P18507; | 100 | 3×NAG; 3×NAG; 1×NAG; 2×ABU; 3×A1ADG; 4×PTY; 2×Q3G; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8foi.1.E | monomer | 0.62 | 1×NAG; 4×D12; 3×OCT; | 99.41 | ||
3 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 1 | 9eqg.1.E | monomer | 0.70 | 1×D10; 1×R16; | 80.30 | ||
| Isoform 3 | 9eqg.1.E | monomer | 0.87 | 87.06 | |||
| Isoform 4 | 9eqg.1.E | monomer | 0.88 | 85.22 | |||